Hans van BruggenChief Scientific Officer at CelegenceSpeaker
Profile
Hans van Bruggen is Chief Scientific Officer at Celegence. He has an MSc in Pharmaceutical Medicine from the University of Surrey (UK) and has worked within, or for, the pharmaceutical industry for more than 40 years in Global or European Headquarters. He has gained a wealth of experience and a comprehensive view on what information is needed to evaluate the benefit/risk ratio of drugs for patients (and healthy volunteers). Using that scientific background, he approaches interdisciplinary and international processes related to data, documents and dossiers.
Agenda Sessions
Facilitating the Digital Transformation of Module 3 to PQ/CMC, IDMP and ICH M4Q R2
, 09:40View Session